ClinConnect ClinConnect Logo
Search / Trial NCT04692714

Evaluation of Two Surgical Strategies for Robotic Implantation of Total Knee Prostheses (Stryker), Cemented Versus Uncemented

Launched by HOSPICES CIVILS DE LYON · Dec 30, 2020

Trial Information

Current as of November 12, 2025

Recruiting

Keywords

Total Knee Arthroplasty Prosthesis Cement Mako Iks Score

ClinConnect Summary

This clinical trial is studying two different surgical methods for total knee replacement surgery, also known as total knee arthroplasty (TKA). The trial aims to compare the use of cemented implants, which are fixed in place with a special glue, versus uncemented implants that rely on the bone to grow into them for stability. Researchers want to see which method works better in terms of how long the implants last and how well patients can move and function after the surgery, especially when robotic assistance is used during the procedure.

To participate in this trial, patients should have been diagnosed with osteoarthritis of the knee and need a total knee replacement for the first time. They should also be able to understand the study and follow the after-surgery care instructions. However, individuals with certain conditions, like rheumatoid arthritis or significant knee deformities, will not be eligible. Participants can expect to undergo TKA with either type of implant and will be monitored for their recovery and the performance of the implants over time. This study is important because it could help improve knee surgery outcomes for many patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of internal, external or global femorotibial knee osteoarthritis
  • Indication for first-line total knee arthroplasty
  • having given informed consent
  • Affiliated with a social security scheme
  • Patient being able to understand the objectives of the study and willing to comply with postoperative instructions.
  • Exclusion Criteria:
  • Patient with rheumatoid arthritis
  • Preoperative flexion less than 90 °
  • Prosthesis associated with an osteotomy
  • History of surgery on the operated knee, except arthroscopy
  • Poor bone quality assessed by the surgeon
  • Knee deformation greater than 10 ° preoperatively (HKA)
  • Pregnant or breastfeeding Women
  • Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care, persons admitted to a health or social institution for purposes other than research
  • Adults subject to a legal protection measure
  • Patient already participating to another clinical trial that might jeopardize the current trial

About Hospices Civils De Lyon

Hospices Civils de Lyon (HCL) is a leading public health institution in France, dedicated to providing high-quality healthcare and advancing medical research. With a rich history dating back to the 18th century, HCL encompasses multiple hospitals and offers a diverse range of services across various medical specialties. The institution is committed to fostering innovative clinical trials that aim to enhance patient care and improve therapeutic outcomes. By collaborating with academic and industry partners, HCL plays a pivotal role in the development of new treatments and the advancement of medical knowledge, ensuring that research efforts are aligned with the highest ethical standards and patient safety protocols.

Locations

Lyon, France

Lyon, France

Patients applied

0 patients applied

Trial Officials

Sébastien LUSTIG, Professor

Principal Investigator

Hospices Civils de Lyon

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials